chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Feeling weird at the work; Feeling a little sick; I function properly but I have like Covid symptoms; Have some COVID symptoms; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 23-years-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EW0158; Expiration Date: 30Jul2021), dose 1 via an unspecified route of administration, administered in Arm Right on 31May2021 as 1ST DOSE, SINGLE DOSE for covid-19 immunisation (23 years old at the time of vaccination). Patient medical history and concomitant medications were reported. When probed for the concern, consumer stated that he started feeling weird at the work the other day because of 1st dose of the Pfizer vaccine and he have gotten that on Monday (31May2021) and he started feeling a little weird, first 3 days he knew was normal. Now it was already 5 days in, and he was still feeling a little sick, had a little bit of COVID symptoms but he did not know if he should be going in to work or not if he does had symptoms. Received follow-up on 05Jun2021, 07Jun2021, Consumer was informed about Pfizer Medical Information Department. He spoke with five persons, but call was not given to medical department. He was asked for dates for already five days since he got vaccinated it was unspecified. Patient did not receive any other prior vaccination. The clinical outcome of events was unknown.
This spontaneous report as received from a Medical Assistant refers to an unspecified number of patients of unknown age and gender. In May and June 2017, the patients were vaccinated with M-M-R II albumin status rHA, lot # L039613 for prophylaxis. In May and June 2017, the patients experienced incorrect product storage. On an unknown date, the patients experienced no adverse event. This is one of 3 reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1708USA009479: US-009507513-1708USA009480:
Delayed rash; A spontaneous report was received from a consumer concerning a 75-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced delayed rash.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Jan 2021, approximately 13 days prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch number: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 27 Jan 2021, the patient experienced delayed rash. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event delayed rash was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Client received a Tdap injection to right deltoid on 8/19//2016 at this clinic by this nurse. Client revisited clinic with this nurse for an unrelated matter on 8/22/2016. Clients' mom requested this RN look at the clients' right arm where the Tdap injection was administered on 8/19/2016. RN lifted clients' right shirt sleeve to find his right upper arm and the Tdap injection site to be red, swollen and warm to the touch. Mom sated she noticed the right arm was very large and swollen on Saturday evening and she applied cold packs to the site. RN asked mom if she had taken client to his doctor for an evaluation. Mom stated she had not done so. RN encouraged mom to take client to their doctor to have his right arm looked at. RN told mom that the clients arm may need medical treatment. RN reviewed the Tdap VIS with mom. Encouraged mom to call the National Vaccine Injury Program. RN informed mom that a VAERS report would be filled out for the event. Mom left clinic stating she was taking the client to the doctors prior to going to school.
Headache  for 2 days  ?Rash? and redness on day 2 &3  Severe arm soreness on day 2, less on day 3
This is a spontaneous report from a contactable consumer (patient). A 45-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6200), at the age of 45, via an unspecified route of administration, in the left arm, on Mar 11, 2021, at 14:00, single dose, for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, patient was diagnosed with COVID-19. Concomitant medications included minocycline hydrochloride and Xyzal (levocetirizine dihydrochloride); both for unknown indication from unknown date and unknown if ongoing. The patient previously received Bactrium (sulfamethoxazole; trimethoprim) on an unknown date for an unknown indication and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Mar 12, 2021, at 14:00, patient experienced fatigue, arm pain, swollen sore lymph node under arm on the injection side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. Since the vaccination, patient has not tested for COVID-19. The outcome of fatigue, arm pain, swollen/sore lymph node underarm on the injection site: recovering (at this time of this report). No follow-up attempts needed. No further information expected.
pt devel a fever which abated;then returned; on 7/2/99, pt hosp & tx w/ATB; father stated pt had a virus in the blood & urine; a moderate case of urinary reflux was reportedly detected;p/10 days pt disch on bactrim therapy;
difficulty stretching left arm; left arm became sore; site of injection is tender; This case was reported by a consumer via call center representative and described the occurrence of injected limb mobility decreased in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injected limb mobility decreased, pain in arm and injection site tenderness. On an unknown date, the outcome of the injected limb mobility decreased, pain in arm and injection site tenderness were not recovered/not resolved.   It was unknown if the reporter considered the injected limb mobility decreased, pain in arm and injection site tenderness to be related to Shingrix.  Additional details were provided as follows: The patient self reported the case. The patient received first dose of Shingrix approximately 4 to 6 weeks ago of reporting date  in left arm (patient did not remember the exact date). The patient's left arm became sore immediately after dose and had remained sore. The soreness had not worsened or lessened, but had remained consistently the same. The patient had difficulty stretching left arm out and need to use right arm to pick up objects such as laptop due to soreness in left arm. The patient mentioned site of injection was still tender to the touch. Arm soreness and decreased mobility were ongoing, all symptoms were ongoing. The patient consented to follow up.
Cold; Sore left arm; This is a spontaneous report from a contactable consumer, the patient.  A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number LC3302), via an unspecified route of administration in the left arm on 12Feb2021 at 17:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation.  Relevant medical history included diabetes (diagnosed 4-5 years ago). The patient did not have any relevant family medical history. Concomitant medications included echinacea and vitamins, both from an unknown date at an unknown dose for an unknown indication and unspecified medications for diabetes, cholesterol and thyroid, all started prior to the vaccine. The patient previously received a shingles shot (unspecified product) for immunization and experienced injection site soreness.  The patient did not receive any other vaccines on same date of the BNT162B2 vaccine and no prior vaccinations within 4 weeks of the vaccine.  On 12Feb2021 the patient experienced a cold approximately five hours after the vaccination (reported as 21:30 - 22:00) which was a little worse on Saturday but started to get better and a sore left arm within a few hours of receiving the vaccine (exact time unknown).  The events did not require a visit to ER or physician's office and there were no relevant tests performed. The patient stated they have not had a cold in over a year and would like to know if it is a symptom of the vaccine. The patient reported she is taking echinacea liquid and it usually helps within 36 hours and now this is her third day. It has gotten better because she takes echinacea and vitamins as well. The patient stated her left arm was sore, but not bad. She first stated it was 3-4 inches above elbow and later stated it was about 4 inches from shoulder and she did not think it was in the muscle. The patient has an appointment for her second dose in 4 weeks, the patient inquired if there will be an issue with her receiving second dose in 4 weeks instead of 3 weeks. The clinical outcome of the cold and sore left arm was recovering.
Around the 3rd or 4th day after taking shot she was having a loud buzzing in her head
Fever chills pain in arm severe headache body aches slight nausea  fatigue. Almost 48 hours and still have headache arm pain nausea. I believe after 36 hours the fever left.
has a sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (has a sore throat) in an adult female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Moderna Covid-19 vaccine (Dose 1 on 26-Feb-2021, lot number: 025M20A and expiration date was not known.), Moderna Covid-19 vaccine (Dose 2 on second 26-Mar-2021 and lot number and expiry date were not provided.). Past adverse reactions to the above products included No adverse event with Moderna Covid-19 vaccine; and Pain in arm with Moderna Covid-19 vaccine.    On 19-Oct-2023, the patient received third dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (has a sore throat). At the time of the report, OROPHARYNGEAL PAIN (has a sore throat) had not resolved.        For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. The patient was driving and cannot provide more information on her previous doses.   This case was linked to US-MODERNATX, INC.-MOD-2023-746605 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-746605:Same Reporter different Product (Moderna covid-19 vaccine )
Pain on my neck; Excruciating pain on back of my head/if head wobble a millimeter, it gives an excruciating pain; My voice sound funny; My left neck is stiffened up; Difficulty in swallowing; Neck started feeling funny; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHONIA (My voice sound funny), FEELING ABNORMAL (Neck started feeling funny), MUSCULOSKELETAL STIFFNESS (My left neck is stiffened up), DYSPHAGIA (Difficulty in swallowing) and NECK PAIN (Pain on my neck) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced FEELING ABNORMAL (Neck started feeling funny). On 05-Apr-2021, the patient experienced DYSPHONIA (My voice sound funny), MUSCULOSKELETAL STIFFNESS (My left neck is stiffened up) and DYSPHAGIA (Difficulty in swallowing). On an unknown date, the patient experienced NECK PAIN (Pain on my neck) and HEADACHE (Excruciating pain on back of my head/if head wobble a millimeter, it gives an excruciating pain). The patient was treated with NAPROXEN at an unspecified dose and frequency; PREDNISONE at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPHONIA (My voice sound funny), FEELING ABNORMAL (Neck started feeling funny), MUSCULOSKELETAL STIFFNESS (My left neck is stiffened up), DYSPHAGIA (Difficulty in swallowing), NECK PAIN (Pain on my neck) and HEADACHE (Excruciating pain on back of my head/if head wobble a millimeter, it gives an excruciating pain) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up information received on 26-May-2021 contains non-significant information
VOMITING; STOMACH ACHE; FEVER; This spontaneous report received from a consumer concerned a 31 year old female. The patient's weight was not reported and height was 66 inches. The patient's concurrent conditions included alcohol use, and non-smoker, and other pre-existing medical conditions included patient had no known drug allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 11-APR-2021, the subject experienced vomiting. On 11-APR-2021, the subject experienced stomach ache. On 11-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, vomiting, and stomach ache. This report was non-serious.
Large swollen knot under the skin. Rash on the skin.  Joint and muscle soreness,  burning
Patient was administered an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine). On 26-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered an expired dose of the Moderna COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.   This case was linked to MOD-2021-365379 (Patient Link).
Rash around injection site on left arm.; swollen  lymph nodes under left arm; painful lymph nodes under left arm; Headache; Inappropriate schedule of vaccine administered.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had allergies to sulfa drugs (unspecified) and codeine (MANUFACTURER UNKNOWN). Concomitant medications included fexofenadine hydrochloride (ALLEGRA), mometasone furoate (NASONEX) and vitamin B complex (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 15Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 31Mar2021 at 18:00, 30 hours after vaccination, the patient experienced rash around injection site on left arm, extremely swollen and painful lymph nodes under left arm and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of events. The clinical outcome of the events rash around injection site on left arm, extremely swollen and painful lymph nodes under left arm and headache was not recovered and the outcome of inappropriate schedule of vaccine administration was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
MUSCLE ACHE (A LITTLE BIT); SORE ARM; NAUSEA; This spontaneous report received from a patient concerned a 55 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029,expiry: UNKNOWN) dose was not reported, administered on 14-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAR-2021, the subject experienced sore arm. On 14-MAR-2021, the subject experienced nausea. On 15-MAR-2021, the subject experienced muscle ache (a little bit). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm, and muscle ache (a little bit), and had not recovered from nausea. This report was non-serious.
Narrative:  Patient received vaccine from outside facility and reported to ER for chest pain/SOB. Patient was transferred to an outside facility ICU for treatment of cardiac tamponade.
This spontaneous report was received from a nurse concerning a patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. On 14-JUN-2016, the patient was vaccinated with an unspecified dose of GARDASIL 9 (Lot # expiration date and dose were not reported) which had been improperly stored during 24 hours at 9.50 C and 144 hours stored at temperatures between 8.01 C to 8.11 C. Concomitant medications were not reported. There was no previous temperature excursion and the call was made because of a data logger. No adverse effects were reported and there was no PQC involved. This is one of several cases from the same source (MARRS # 1607USA004298 and 1607USA006956). Additional information has been requested.
PATIENT WAS ADMINISTERED HAVRIX AND FLUARIX INTRAMUSCULARLY AT HER WORKPLACE ON 10/12/2017. PATIENT CALLED THE PHARMACY TODAY 11/14/2017 TO INFORM THAT HER ARM IS SORE AND PAINFUL. I ADVISED HER TO CALL HER DOCTOR FOR EVALUATION AND INFORMED HER THAT I WOULD BE SUBMITTING VAERS FORM.
Redness and itching in left arm, chest, and both hands. Pt states SX started @2130 on 17NOV2020
Back pain - lower back and between shoulder blades. Began the morning after vaccine and continued for the whole day.
palmar rash started a few hours after the vaccination. Red spots on the abdomen about 2 days after the vaccine.
hives; This is a spontaneous report from a contactable consumer or other non hcp (Patient himself). A 81-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection,Batch/Lot Number: EL9262), dose 1 via an unspecified route of administration, administered in Arm Left on 01Feb2021 16:00 (age at the time of vaccination was 81-year-old)  as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history, concomitant medications were not reported. Facility type vaccine: Doctor's office/urgent care. The patient has no other vaccine in 4 week. The patient has not tested covid prior vaccination and post vaccination.On 14Feb2021 The patient experienced hives. The outcome of event was unknown.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced mild symptoms which lasted for 7 days. No complications or treatment was noted.
05Dec90 pt vax w/ hepta B;  exp tightness in chest that lasted more than 36 hrs. Recovered w/in 36 hrs; no problems w/ 2nd dose.
Hospital Course:  50 year old vaccinated female was admitted for Covid-19 pneumonia with respiratory failure. She was treated with Remdesivir and steroids. She has improved after 3 doses of Remdesivir and discharged home in stable condition. Patient educated on appropriate level of care post-discharge. Follow up with Primary Care Doctor in 5-7 days.   Physical Exam on the day of discharge: Last Recorded Vital Signs: Temp: 97.6 °F (36.4 °C) Heart Rate (Monitor): 83 Pulse: 66 BP: 117/68 Respirations: 16 SpO2: 100 % O2 Flow Rate (l/min): 2 l/min General Appearance: no distress  Eyes: PERRLA ENT: moist mucus membranes, no adenopathy Lungs: clear to auscultation bilaterally  Heart: regular rate and rhythm Abdomen: soft, non-tender  Skin: No rashes or lesions  Extremities: full ROM Neuro: alert, normal strength and tone    Consults:  IP CONSULT TO WOUND CARE   Significant Diagnostic Studies:   CXR   Operations: none   Disposition:  Home    Discharge Condition:  Fair
Vaccine applied to a 15 years old person; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine applied to a 15 years old person) in a 15-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine applied to a 15 years old person). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine applied to a 15 years old person) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported by reporter. No Treatment information was reported by reporter.
Unknown. Unable to speak with case due to hospitalization. POA stated that case has been hospitalized frequently since 11/2022.
After approximately 24 hours after 2nd dose of Moderna, ppt noted left eyelid was starting to droop. She was seen by PCP (4/1/2021) and determined to have Bell's Palsy. She was started on Prednisone 60mg daily x 7 days.
After 2nd Moderna shot, severe pain developed in left shoulder, and range of motion was totally  limited for arm movement forward, sideways, up or back. It became painful to do any routine function. Finally went to ortho doc on 4/7and they took X-ray. Showing no bone issues. Injected steroid into shoulder.  Did PT exercises. Little  relief by visit on 5/14 . 6/9 returned to NSO, was given Ascent shot...some improvement. MRI conducted on 6/17 showed extreme inflammation in joint.
Patient experienced itching all over the evening of vaccination (approximately 6-10 hours post-vaccination. Patient took 25mg diphenhydramine and itching resolved until following morning. Patient then called pharmacy and was advised to take additional antihistamine as needed and to follow up with urgent care if symptoms worsened over the weekend.